Aaron M. D’Antona
Pfizer (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Viral Infectious Diseases and Gene Expression in Insects, Protein purification and stability, Glycosylation and Glycoproteins Research, Receptor Mechanisms and Signaling
Most-Cited Works
- → The structural basis of agonist-induced activation in constitutively active rhodopsin(2011)464 cited
- → Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors(2004)173 cited
- → Membrane Assembly of the Cannabinoid Receptor 1: Impact of a Long N-Terminal Tail(2003)123 cited
- → Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer(2016)94 cited
- → Mutations of CB1 T210 Produce Active and Inactive Receptor Forms: Correlations with Ligand Affinity, Receptor Stability, and Cellular Localization(2006)58 cited
- → Modeling and mitigation of high-concentration antibody viscosity through structure-based computer-aided protein design(2020)50 cited
- → Transient CHO expression platform for robust antibody production and its enhanced N‐glycan sialylation on therapeutic glycoproteins(2018)44 cited
- → Recent Advances in the Molecular Design and Applications of Multispecific Biotherapeutics(2021)43 cited
- → Complement Activation by Adeno-Associated Virus-Neutralizing Antibody Complexes(2023)35 cited
- → Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney disease(2020)28 cited